Skip to main content

Table 1 Summary of the main predictive scores developed for patients under VA-ECMO for refractory cardiogenic shock

From: Predicting clinical outcome in patients undergoing VA-ECMO

Study

Year

Population

Sample size

Outcome prediction

Number of items retained/number of deaths

Internal Validation

AUROC

External validation

Schmidt et al. [7]

2015

General RCS multicentric

3846

In-hospital survival

12/2245

Yes

0.68 [95% CI 0.66–0.69]

Yes

AUROC 0.90 [95% CI 0.85–0.95]

Muller et al. [9]

2016

Post AMI RCS bicentric

138

In-hospital survival

7/65

Yes

0.84 (95% CI 0.77–0.91

No

Wang et al. [10]

2018

Post CABG monocentric

166

In-ICU mortality

6/92

Yes

0.85 (95% CI 0.79–0.91)

No

  1. AUROC area under receiver operating characteristics, RCS refractory cardiogenic shock, AMI acute myocardial Infarction, CABG coronary artery bypass grafting